Therapy (TB)
"Periodontal Indices of Patients Taking Isoniazid and Rifampin: A Pilot Study."
Published in TB and Outbreaks Week, February 24th, 1997
According to the authors' abstract of an article published in Military Medicine, "A significant reduction in the incidence of tuberculosis (TB) has resulted from the use of medications such as isoniazid (MH) and rifampin. Unfortunately, there has been a resurgence of TB since the mid 1980s. The purpose of this pilot study was to evaluate the effects of INH and rifampin on periodontal indices of patients with positive tuberculin skin tests (PPD). The gingival index, plaque index, and periodontal scoring and recording were recorded in PPD-positive patients at baseline and 1 month. Control patients received no medications during the study and were evaluated at baseline and 1 month. Mean...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Therapy (TB)
IL-12 May Benefit Immunosuppressed MDR-TB Patients - Immunogenicity (TB)
Novel Antigen MPT6 Cloned and Characterized - Immunology (TB)
Perforin Cytotoxicity Unnecessary for Infection Control - Inflammatory Response (TB)
Granulomas Act as Centers of Fibrogenesis - Influenza
Revaccinations Not Necessary After Flu Vaccine Recall - Pathogenesis (TB)
M. tb Infection Promotes Alveolar Macrophage Apoptosis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
